Abstract
Summary
A modelling approach is uscd to analyse the cost effectiveness of prescribing angiotensin converting enzyme (ACE) inhibitors, compared with standard practice, as first-line therapeutic agents in the treatment of hean failure in The Netherlands. Data concerning costs, incidence. prevalence and survival are used to construct an age-dependent semi-Markov-chain model. Two scenarios are compared. The first reflects the continuation of common practice. The second. containing assumptions made on the basis of results from randomised clinical trials, reflects the situation in which ACE inhibitors are given as first-lin e pharmacotherapy. Conditional on the esti mates and assumptions made. it is shown that prescribing ACE inhibitors as first-tine pharmacotherapy will improve survival by about 4% over the first 10 years. and will save about 17% in costs over the first 10 years. Sensiti vity analysis shows the robustness of the conclusio ns to all major parameters.
Similar content being viewed by others
References
Captopril Multicenter Research Group. A placebo-controlled trial of Captopril in refractoly chronic congestive heart faillire. Journal of the American College of Cardioqy 63: 755–763, 1983
Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with caplopriland dilOain in patients with mild to moderate heart failure. Journal oftht American Medial Aswciation 259: 519–544, 1988
Chatterjee K, Parmley WP, Colin JN, Levine TB, Awan NA, et al. (Captopril Multicenter Research Group I). A cooperative multicenter study of C1lptopril in Congestivet heart failure: hemodynamic effects and long-term rnponse. American Heart Journal 110: 439–441, 1985
Cleland JGF. ACE-inhibitors in mild heart failure: first-line or second-line therapy? European Heart Journal 11: 53–57, 1990
Cohn IN, Archibald DG, Zinche S, Franciosa JA, Hartson WE, et al. Effcts of vasodilator therapy on mortality in chronic congestive heart failure. New England Journal of Medicine: 314: 1547–1552, 1986
Cohn IN, Rector TS. ProsnOsis or congestive titan faillln: and prediclon of mortality. American Journal ofCaroiolOgy 62: 25A–30A, 1988
Cotln IN, Jotlnson G, Ziesctle S, Cobb F, Francis G, et al. A compariwn of enllapril with hydralazineisorbic: le din ilrale in the tratment of ctlronic congestivc heart failure. New England Journal of Medicine 325: 303–310, 1991
Consensus (Cooperative Nonh Scandinavian Enalapril Slirvival Study). Effects of enalapril on monality in seven: congestive heart failure. New England Journal of Medicine 316: 1429–1435, 1987
Franciosa JA, Wilen M, Ziesche S, Cohn IN. Survival in men with severe chronic left ventricular failure due to either roronary titan disease or idiopathic dilated cardiomyopathy. American Journal of Cardiology 51: 831–836, 1983
Kannel WB. Epidemioloay find prevention of cflrdiac failure: Framingham study in sights. European Hean Journal 8: 23–29, 1987
Kannel WB, Plehn JF, Cupples LA. Cardiac faillire and sudden death in tlw: — framingham Study. American Heart Journal 115: 869–875, 1988
Kannel WO. Epidcmiological aspects of heart failure. CardiolOgy Clinics 7: 1–9, 1989
Koopmanschap MA, Roijen L, van Bonneux L. Kosltn va n lieklen in Nederland. Report of the Depanmcnt of Public Health and Social Medicine and the Institute for Medical Tectlnoiosy Assessment, Erasmus University Rotterdam. Rollmam, 1991
Koopmanschap MA, van Ineveld BM. Towards a new approach for Hlimalinl indirect costs of disease. Social Sciece and and Medicine 34: 100S–1010, 1992
McFate Smith W. Epidiomiology of ronaestive hurt failure. American Journal of Cardioipsy 55: 3A–8A, 1985
Parmley WW. PathophysiololY and Current therapy of conscstivc hnrt failure. Journal of the American College for Cardiology 13: 771–785, 1989
Poole-WilsOn PA. Future persptctives in the managemen t of congestive Man failure. American Journal of Cardiology 60: 462–467, 1990
Remcs J, Miettinen H, Rellnantent A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. European Hcan JOurnal 12: 315–321, 1991
SOLVD-investigators. Effect of Enalapril on survival in patients with redllccd left ventriclil ar ejection frictions and conscstive heart failuft. New England Journal of Medicine 325: 293–302, 1991
van der Velden J. Nationale studie van tick ten en verrichlintcn en de tluisaruenpr1lklijk. Mtdiseh Contact 45: 60–74, 1990
Wilson JR. Prosn0sis in severe heart failure: relation to hemodynamic measurements and venlricular ectopic activity. Journal of the American College of Cardiogy 2: 403–441, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Hour, B.A., Wielink, G., Bonsel, G.J. et al. Effects of ACE Inhibitors on Heart Failure in The Netherlands. Pharmacoeconomics 3, 387–397 (1993). https://doi.org/10.2165/00019053-199303050-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199303050-00006